National Healthcare Agreement: PI 02–Incidence of selected cancers, 2017
Identifying and definitional attributes
|Metadata item type:||Indicator|
|Indicator type:||Progress measure|
|Short name:||PI 02–Incidence of selected cancers, 2017|
|Registration status:||Health, Superseded 30/01/2018|
Incidence of selected cancers of public health importance.
|Indicator set:||National Healthcare Agreement (2017) Health, Superseded 30/01/2018|
|Outcome area:||Prevention Health, Standard 07/07/2010|
|Quality statement:||National Healthcare Agreement: PI 02-Incidence of selected cancers, 2017 QS Health, Standard 31/01/2017|
Collection and usage attributes
Rates directly age-standardised to the 2001 Australian population.
Analyses by state and territory, remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-economic Disadvantage (IRSD) are based on the state or territory and Statistical Area Level 2 (SA2) of the person at the time of their diagnosis.
Rates that are considered unstable and should be interpreted with caution will be noted. Rates that are considered very unstable will not be published.
100,000 × (Numerator ÷ Denominator)
Calculated separately for each type of cancer.
For melanoma, bowel and lung cancer: Number of new cases in the reported year.
For cervical and breast cancer in females: Number of new cases in females in the reported year.
|Numerator data elements:|
For melanoma, bowel and lung cancer: Total population.
For cervical and breast cancer in females: Total female population.
|Denominator data elements:|
2011, 2012 (resupplied for updated NSW and ACT data), 2013—Nationally (for each cancer type), by 2011 SEIFA IRSD deciles (not reported).
2011, 2012 (resupplied for updated NSW and ACT data), 2013—State and territory (for each cancer type).
2011, 2012 (resupplied for updated NSW and ACT data) (not reported), 2013—State and territory (for each cancer type), by:
2011, 2012 (resupplied for updated NSW and ACT data), 2013—State and territory (for each cancer type), by:
Some disaggregation may result in numbers too small for publication.
Disaggregation by SEIFA and remoteness data are subject to availability of suitable population data.
|Disaggregation data elements:|
Most recent data available for 2017 National Healthcare Agreement performance reporting: 2012 for NSW and 2013 for all other jurisdictions.
2011 and 2012 data will be resupplied to include data for NSW and the ACT, which were not available for the 2015 or 2016 reports.
NSW data for 2013 are not available.
|Unit of measure:||Disease type|
Indicator conceptual framework
|Framework and dimensions:||Health conditions|
Data source attributes
National Healthcare Agreement
|Organisation responsible for providing data:|
Australian Institute of Health and Welfare
|Further data development / collection required:|
Specification: Final, the measure meets the intention of the indicator.
|Related metadata references:|
Supersedes National Healthcare Agreement: PI 02–Incidence of selected cancers, 2016 Health, Superseded 31/01/2017
Has been superseded by National Healthcare Agreement: PI 02–Incidence of selected cancers, 2018 Health, Superseded 19/06/2019
See also National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2017 Health, Superseded 30/01/2018